Use of Antifibrotics to Prevent Ventriculoperitoneal Shunt Complications Due to Intra-abdominal Fibrosis: Experimental Study in a Rat Model.

Aydoseli, AYDIN; Tahta, Alican; Aras, YAVUZ; Sabanci, PULAT; Keskin, METİN; Balik, Emre; Onder, SEMEN; Sencer, ALTAY; Izgi, Ali

doi:10.1055/s-0034-1389369

Use of Antifibrotics to Prevent Ventriculoperitoneal Shunt Complications Due to Intra-abdominal Fibrosis: Experimental Study in a Rat Model.

Aydoseli A., Tahta A., Aras Y., Sabanci A., Keskin M., Balik E., ...Daha Fazla

Journal of neurological surgery. Part A, Central European neurosurgery, cilt.76, sa.3, ss.219-23, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 76 Sayı: 3
Basım Tarihi: 2015
Doi Numarası: 10.1055/s-0034-1389369
Dergi Adı: Journal of neurological surgery. Part A, Central European neurosurgery
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.219-23
İstanbul Üniversitesi Adresli: Evet

Özet

Background Cerebrospinal fluid shunt operations have reduced the morbidity and mortality of hydrocephalus, but have potential complications. Ventriculoperitoneal (vp) shunt obstruction is one of the common complications of shunt surgery. The obstruction is caused by fibrosis and is usually located on the tip of the ventricular and/or peritoneal catheter.